Abstract
This study investigated the potential genes and related pathways in burn-induced myocardial injury. Rat myocardial injury induced by third-degree burn and the histopathological structures, apoptosis, and cardiac injury markers were then identified using hematoxylin & eosin staining, terminal deoxynucleotidyl transferase-mediated dUTP nick end labeling staining, and enzyme-linked immunosorbent assay. Next, differentially expressed mRNAs were screened through next-generation sequencing (NGS), followed by functional annotation and key gene validation through quantitative reverse transcription-polymerase chain reaction. Subsequently, CD14 was screened out, and small interfering RNAs against CD14 were transfected to H9C2 cells to further verify the role of CD14 in burn-induced injury. The results showed that third-degree burn could markedly damage the structure of myocardial tissue, induce the apoptosis of myocardial cells, and increase the levels of myocardial injury-related markers, suggesting that burns could induce myocardial injury in rats. Besides, NGS data discovered that third-degree burn could result in 416 differentially upregulated mRNAs and 285 differentially downregulated mRNAs in myocardial tissue. It was also disclosed that differentially expressed mRNAs were mainly enriched in the phosphatidylinositol 3-kinase/Akt, mitogen-activated protein kinase (MAPK), and tumor necrosis factor signaling pathways. Furthermore, cell viability was significantly decreased in H9C2 cells treated with 10% rat burn serum. CD14 was significantly differentially expressed and screened out for further studies. Treatment with burn serum can significantly upregulate the phosphorylation level of extracellular signal-regulated kinase, p38, and c-Jun N-terminal kinase and the expression of cleaved caspase-3 and downregulate the expression of Bcl2 when compared with those in negative control of small interfering RNA transfected H9C2 cells, whereas interfering with CD14 expression reversed the effects of burn serum. The study demonstrated that burn serum treatment could activate the MAPK signaling pathway to promote cell apoptosis, and it can be reversed by interfering with the expression of CD14.
Similar content being viewed by others
References
Magne, J. (2002). [Psychological aspects of burns]. Pathologie Biologie (Paris), 50, 134–136.
Huang, Y., Li, Z., & Yang, Z. (2003). Roles of ischemia and hypoxia and the molecular pathogenesis of post-burn cardiac shock. Burns, 29, 828–33.
Weitgasser, L., Ihra, G., Schäfer, B., Markstaller, K., & Radtke, C. (2021). Update on hyperbaric oxygen therapy in burn treatment. Wiener Klinische Wochenschrift, 133, 137–143.
Clemmensen, T. S., Soerensen, J., Hansson, N. H., Tolbod, L. P., Harms, H. J., & Eiskjær, H., et al. (2018). Myocardial oxygen consumption and efficiency in patients with cardiac amyloidosis. Journal of the American Heart Association, 7, e009974.
He, W., Wang, Y., Wang, P., & Wang, F. (2019). Intestinal barrier dysfunction in severe burn injury. Burns & Trauma, 7, 24.
Xiao, R., Teng, M., Zhang, Q., Shi, X. H., & Huang, Y. S. (2012). Myocardial autophagy after severe burn in rats. PLoS ONE, 7, e39488.
Kramer, G.C., Lund, T., & Beckum, O.K. (2007). Pathophysiology of burn shock and burn edema. In: Herndon DN (Ed) Total Burn Care (Third Edition), Elsevier Inc. 93–106.
Tewelde, S. Z., Liu, S. S., & Winters, M. E. (2018). Cardiogenic shock. Cardiolology Clinics, 36, 53–61.
Plassais, J., Venet, F., Cazalis, M. A., Le Quang, D., Pachot, A., & Monneret, G., et al. (2017). Transcriptome modulation by hydrocortisone in severe burn shock: ancillary analysis of a prospective randomized trial. Critical Care, 21, 158.
Reyentovich, A., Barghash, M. H., & Hochman, J. S. (2016). Management of refractory cardiogenic shock. Nature Reviews Cardiology, 13, 481–92.
Lim, H. S. (2016). Cardiogenic shock: failure of oxygen delivery and oxygen utilization. Clinical Cardiology, 39, 477–83.
Levy, S. E., & Myers, R. M. (2016). Advancements in next-generation sequencing. Annual Review of Genomics and Humun Genetics, 17, 95–115.
Slatko, B. E., Gardner, A. F., & Ausubel, F. M. (2018). Overview of next-generation sequencing technologies. Current Protocol in Molecular Biology, 122, e59.
de Klerk, E., & t Hoen, P. A. (2015). Alternative mRNA transcription, processing, and translation: insights from RNA sequencing. Trends in Genetics, 31, 128–39.
Martin, D.P., Miya, J., Reeser, J.W., & Roychowdhury, S. (2016). Targeted RNA sequencing assay to characterize gene expression and genomic alterations. Journal of Visualized Experience, 4, 54090.
Byron, S. A., Van Keuren-Jensen, K. R., Engelthaler, D. M., Carpten, J. D., & Craig, D. W. (2016). Translating RNA sequencing into clinical diagnostics: opportunities and challenges. Nature Reviews Genetics, 17, 257–71.
Potter, S. S. (2018). Single-cell RNA sequencing for the study of development, physiology and disease. Nature Reviews Nephrology, 14, 479–92.
Gao, R., Kim, C., Sei, E., Foukakis, T., Crosetto, N., & Chan, L. K., et al. (2017). Nanogrid single-nucleus RNA sequencing reveals phenotypic diversity in breast cancer. Nature Communications, 8, 228.
Wang, J., Dean, D. C., Hornicek, F. J., Shi, H., & Duan, Z. (2019). RNA sequencing (RNA-Seq) and its application in ovarian cancer. Gynecologic Oncology, 152, 194–201.
Ackers-Johnson, M., Tan, W. L. W., & Foo, R. S. (2018). Following hearts, one cell at a time: recent applications of single-cell RNA sequencing to the understanding of heart disease. Nature Communications, 9, 4434.
Du, M., Dong, R., & Zheng, S. (2019). Single-cell RNA sequencing of T cells in crohn’s disease. Gastroenterology, 157, 265–6.
Giannopoulou, E. G., Elemento, O., & Ivashkiv, L. B. (2015). Use of RNA sequencing to evaluate rheumatic disease patients. Arthritis Research & Therapy, 17, 167.
Kalayinia, S., Goodarzynejad, H., Maleki, M., & Mahdieh, N. (2018). Next generation sequencing applications for cardiovascular disease. Annals of Medicine, 50, 91–109.
Abdullahi, A., Amini-Nik, S., & Jeschke, M. G. (2014). Animal models in burn research. Cellular and Molecular Life Sciences, 71, 3241–55.
Shen, S., Kong, J., Qiu, Y., Yang, X., Wang, W., & Yan, L. (2019). Identification of core genes and outcomes in hepatocellular carcinoma by bioinformatics analysis. Journal of Cellular Biochemistry, 120, 10069–81.
Klopfenstein, D. V., et al. (2018). GOATOOLS: A Python library for Gene Ontology analyses. Scientific Reports, 8, 10872.
Kanehisa, M., Goto, S., Kawashima, S., Okuno, Y., & Hattori, M. (2004). The KEGG resource for deciphering the genome. Nucleic Acids Research, 32, D277–280. Database issue.
Cao, W., Xie, Y. H., Li, X. Q., Zhang, X. K., Chen, Y. T., & Kang, R., et al. (2011). Burn-induced apoptosis of cardiomyocytes is survivin dependent and regulated by PI3K/Akt, p38 MAPK and ERK pathways. Basic Research in Cardiology, 106, 1207–20.
Guillory, A. N., Clayton, R. P., Herndon, D. N., & Finnerty, C. C. (2016). Cardiovascular dysfunction following burn injury: what we have learned from rat and mouse models. International Journal of Molecular Sciences, 17, 53.
Lv, G. F., Dong, M. L., Hu, D. H., Zhang, W. F., Wang, Y. C., & Tang, C. W., et al. (2011). Insulin-mediated inhibition of p38 mitogen-activated protein kinase protects cardiomyocytes in severe burns. Journal of Burn Care & Research, 32, 591–9.
Huang, Y. S. (2018). [Autophagy and hypoxic ischemic myocardial damage after severe burn]. Zhonghua Shao Shang Za Zhi, 34, 3–7.
Jentzer, J. C., Chonde, M. D., & Dezfulian, C. (2015). Myocardial dysfunction and shock after cardiac arrest. BioMed Research International, 2015, 314796.
Tril, V. E., Burlutskaya, A. V., & Polischuk, L. V. (2019). Metabolic cardiomyopathy in pediatrics. Reviews in Cardiovascular Medicine, 20, 73–80.
Stark, R., Grzelak, M., & Hadfield, J. (2019). RNA sequencing: the teenage years. Nature Reviews Genetics, 20, 631–56.
Hedlund, E., & Deng, Q. (2018). Single-cell RNA sequencing: technical advancements and biological applications. Molecular Aspects of Medicine, 59, 36–46.
Harris, M. A., et al. (2004). The Gene Ontology (GO) database and informatics resource. Nucleic Acids Research, 32, D258–261. Database issue.
Hu, R. H., Yu, Y. M., Costa, D., Young, V. R., Ryan, C. M., & Burke, J. F., et al. (1998). A rabbit model for metabolic studies after burn injury. Journal of Surgical Research, 75, 153–60.
Horton, J. W., Sanders, B., White, D. J., & Maass, D. L. (2006). The effects of early excision and grafting on myocardial inflammation and function after burn injury. The Journal of Trauma, 61, 1069–77.
Jandziol, A., & Hayes, M. (2008). The cardiovascular response to burn injury. Current Anaesthesia & Critical Care, 19, 269–74.
Timmers, L., et al. (2009). Exenatide reduces infarct size and improves cardiac function in a porcine model of ischemia and reperfusion injury. Journal of the American College of Cardiology, 53, 501–10.
Falck, G., Skarra, S., & Jynge, P. (1999). Cardiac contractile function and electrolyte regulation during hyperosmolal stress: an experimental study in the isolated rabbit heart. Pharmacology & Toxicology, 84, 174–80.
Swirski, F. K., & Nahrendorf, M. (2018). Cardioimmunology: the immune system in cardiac homeostasis and disease. Nature Reviews Immunology, 18, 733–44.
Xie, Y., Shi, X., Sheng, K., Han, G., Li, W., & Zhao, Q., et al. (2019). PI3K/Akt signaling transduction pathway, erythropoiesis and glycolysis in hypoxia (Review). Molecular Medicine Reports, 19, 783–91.
Weeks, K. L., Bernardo, B. C., Ooi, J. Y. Y., Patterson, N. L., & McMullen, J. R. (2017). The IGF1-PI3K-Akt signaling pathway in mediating exercise-induced cardiac hypertrophy and protection. Advances in Experimental Medicine and Biology, 1000, 187–210.
Sun, Y., Liu, W. Z., Liu, T., Feng, X., Yang, N., & Zhou, H. F. (2015). Signaling pathway of MAPK/ERK in cell proliferation, differentiation, migration, senescence and apoptosis. Journal of Receptor & Signal Transduction Research, 35, 600–4.
Du, X. J., Wei, J., Tian, D., Yan, C., Hu, P., & Wu, X., et al. (2019). NEAT1 promotes myocardial ischemia-reperfusion injury via activating the MAPK signaling pathway. Journal of Cellular Physiology, 234, 18773–80.
Ren, G. D., Y, Y. C., Li, W. L., Li, F. F., & Han, X. Y. (2019). Research on cardioprotective effect of irbesartan in rats with myocardial ischemia-reperfusion injury through MAPK-ERK signaling pathway. European Review for Medical and Pharmacological Sciences, 23, 5487–94.
Padmavathi, G., Banik, K., Monisha, J., Bordoloi, D., Shabnam, B., & Arfuso, F., et al. (2018). Novel tumor necrosis factor-α induced protein eight (TNFAIP8/TIPE) family: functions and downstream targets involved in cancer progression. Cancer Letters, 432, 260–71.
Tian, M., Yuan, Y. C., Li, J. Y., Gionfriddo, M. R., & Huang, R. C. (2015). Tumor necrosis factor-α and its role as a mediator in myocardial infarction: A brief review. Chronic Diseases and Translational Medicine, 1, 18–26.
Cho, K., Pham, T. N., Crivello, S. D., Jeong, J., Green, T. L., & Greenhalgh, D. G. (2004). Involvement of CD14 and toll-like receptor 4 in the acute phase response of serum amyloid A proteins and serum amyloid P component in the liver after burn injury. Shock, 21, 144–50.
Cho, K., Thomas, R. L., & Greenhalgh, D. G. (2003). CD14-dependent regulation of Grp78 in the liver and lungs of mice after burn injury. Experimental and Molecular Pathology, 75, 148–53.
Steinstraesser, L., Alarcon, W., Fan, M. H., Klein, R. D., Aminlari, A., & Zuccaro, C., et al. (2002). Thermal injury induces expression of CD14 in human skin. Burns, 28, 223–30.
Barber, R. C., Aragaki, C. C., Chang, L. Y., Purdue, G. F., Hunt, J. L., & Arnoldo, B. D., et al. (2007). CD14-159 C allele is associated with increased risk of mortality after burn injury. Shock, 27, 232–7.
Barber, R. C., Maass, D. L., White, D. J., Chang, L. Y., & Horton, J. W. (2008). Molecular or pharmacologic inhibition of the CD14 signaling pathway protects against burn-related myocardial inflammation and dysfunction. Shock, 30, 705–13.
An, D., Hao, F., Hu, C., Kong, W., Xu, X., & Cui, M. Z. (2017). JNK1 mediates lipopolysaccharide-induced CD14 and SR-AI expression and macrophage foam cell formation. Frontiers in Physiology, 8, 1075.
Grahnert, A., Weiss, R., Schilling, E., Stanslowsky, N., Sack, U., & Hauschildt, S. (2019). CD14 counterregulates lipopolysacharide-induced tumor necrosis factor-α production in a macrophage subset. Journal of Innate Immunity, 11, 359–74.
Funding
The study was funded by the National Natural Science Foundation of China (81772080).
Author information
Authors and Affiliations
Contributions
X.Z. conceived and designed the study and critically revised the paper. Z.Z. performed the experiments, analyzed the data, and drafted the paper. B.Z., S.G., D.Z., J.G., B.C., and H.H. participated in the study design, study implementation, and paper revision. All authors read and approved the final paper.
Corresponding author
Ethics declarations
Conflict of Interest
The authors declare no competing interests.
Ethics Approval
All animal programs were approved by the animal ethics committees of the Forevergen Laboratory Animal Center.
Additional information
Publisher’s note Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
About this article
Cite this article
Zhu, Z., Zou, B., Gao, S. et al. CD14 Involvement in Third-degree Skin Burn-induced Myocardial Injury via the MAPK Signaling Pathway. Cell Biochem Biophys 80, 139–150 (2022). https://doi.org/10.1007/s12013-021-00995-w
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s12013-021-00995-w